Long-read single-cell sequencing reveals expressions of hypermutation clusters of isoforms in human liver cancer cells.
computational biology
human
mutation evolution pathway
mutation gene expression
mutation isoform expression
single-cell synthetic long-read sequencing
single-molecule mutation evolution
systems biology
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
11 Jan 2024
11 Jan 2024
Historique:
medline:
12
1
2024
pubmed:
11
1
2024
entrez:
11
1
2024
Statut:
epublish
Résumé
The protein diversity of mammalian cells is determined by arrays of isoforms from genes. Genetic mutation is essential in species evolution and cancer development. Accurate long-read transcriptome sequencing at single-cell level is required to decipher the spectrum of protein expressions in mammalian organisms. In this report, we developed a synthetic long-read single-cell sequencing technology based on LOOPSeq technique. We applied this technology to analyze 447 transcriptomes of hepatocellular carcinoma (HCC) and benign liver from an individual. Through Uniform Manifold Approximation and Projection analysis, we identified a panel of mutation mRNA isoforms highly specific to HCC cells. The evolution pathways that led to the hyper-mutation clusters in single human leukocyte antigen molecules were identified. Novel fusion transcripts were detected. The combination of gene expressions, fusion gene transcripts, and mutation gene expressions significantly improved the classification of liver cancer cells versus benign hepatocytes. In conclusion, LOOPSeq single-cell technology may hold promise to provide a new level of precision analysis on the mammalian transcriptome.
Identifiants
pubmed: 38206124
doi: 10.7554/eLife.87607
pii: 87607
doi:
pii:
Substances chimiques
Protein Isoforms
0
Banques de données
GEO
['GSE223743']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : 1R56CA229262-01
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30- DK120531-01
Pays : United States
Organisme : NIH HHS
ID : UL1TR001857 and S10OD028483
Pays : United States
Informations de copyright
© 2023, Liu et al.
Déclaration de conflit d'intérêts
SL, YY, BR, WW, AO, AS, JL No competing interests declared, TB He is an employee of Element Biosciences, Inc, CO She is an employee of Element Biosciences, Inc, MS MS is an employee of Element Biosciences, Inc
Références
PLoS Genet. 2022 Aug 4;18(8):e1010342
pubmed: 35926060
Lancet Oncol. 2016 Jun;17(6):e254-e262
pubmed: 27299281
Nat Commun. 2018 Mar 12;9(1):1026
pubmed: 29531227
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Semin Oncol Nurs. 2002 Feb;18(1 Suppl 1):16-21
pubmed: 11878047
Biomed Res Int. 2020 Aug 03;2020:9578484
pubmed: 32802887
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Pathol Res Pract. 2022 May;233:153870
pubmed: 35390632
Mol Carcinog. 2017 Feb;56(2):315-324
pubmed: 27148859
Genome Res. 2018 Jul;28(7):1096
pubmed: 29967126
Cell Mol Life Sci. 2022 Aug 4;79(8):464
pubmed: 35925520
Nature. 2020 Feb;578(7793):122-128
pubmed: 32025013
Nat Rev Genet. 2020 Oct;21(10):597-614
pubmed: 32504078
Am J Pathol. 2014 Oct;184(10):2840-9
pubmed: 25238935
Int Immunopharmacol. 2021 Dec;101(Pt A):108183
pubmed: 34649092
Nat Biotechnol. 2018 Oct 15;:
pubmed: 30320766
Elife. 2024 Jan 11;12:
pubmed: 38206124
Hum Cell. 2017 Jul;30(3):149-161
pubmed: 28364362
Nat Commun. 2018 Oct 18;9(1):4337
pubmed: 30337524
Semin Cancer Biol. 2019 Dec;59:23-35
pubmed: 31255772
Sci Rep. 2021 Mar 5;11(1):5325
pubmed: 33674641
Nat Biotechnol. 2017 Jun;35(6):543-550
pubmed: 28459452
Hepatology. 2019 Sep;70(3):1011-1025
pubmed: 30637779
J Biol Chem. 2015 Jan 16;290(3):1404-11
pubmed: 25425645
JHEP Rep. 2022 Feb 12;4(4):100449
pubmed: 35295767
Front Oncol. 2021 Feb 19;11:622076
pubmed: 33680966
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Blood. 2004 Jan 15;103(2):630-8
pubmed: 12947002
Mol Immunol. 2022 Apr;144:44-48
pubmed: 35184022
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Commun Biol. 2021 Apr 27;4(1):506
pubmed: 33907296
Nat Rev Cancer. 2010 Apr;10(4):254-66
pubmed: 20332778
Hepatology. 2006 Oct;44(4):1012-24
pubmed: 17006932
Nat Rev Genet. 2021 Jan;22(1):3-18
pubmed: 32807900
Life (Basel). 2021 Dec 26;12(1):
pubmed: 35054423
Genes Dev. 2003 Feb 15;17(4):419-37
pubmed: 12600935
Hepatol Commun. 2022 Apr;6(4):710-727
pubmed: 34725972
PLoS One. 2014 Apr 03;9(4):e92820
pubmed: 24699316
Science. 1991 Jul 5;253(5015):49-53
pubmed: 1905840
Nature. 2021 Oct;598(7881):473-478
pubmed: 34646017
J Labelled Comp Radiopharm. 2017 May 15;60(5):234-241
pubmed: 28181275
Nature. 2022 Feb;602(7897):510-517
pubmed: 35140399
Blood. 2012 May 10;119(19):4451-61
pubmed: 22461490
Sci Rep. 2019 Jan 31;9(1):1074
pubmed: 30705370
Oncotarget. 2019 May 21;10(36):3352-3360
pubmed: 31164957
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Rev Immunol. 2021 Aug;21(8):499-513
pubmed: 33547421
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242